Pay in 4 interest-free payments of $5.38 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
AOD-9604 vs MOTS-c: Side-Effect Profile Head-to-Head At a glance FDA approval status / Neither peptide is FDA-approved for any indication Head-to-head trials / None exist
A Phase 2 trial for ulcerative colitis was conducted by Diagen (Croatia)
NAD+ (IV and Injection) NAD+ plays a key role in mitochondrial function and cellular repair
Pull back slightly on the plunger to check for blood (aspiration)
A consistent schedule during the correction phase keeps levels more stable, which supports normal energy metabolism at the cellular level
US$ 25.76
US$ 20.54
US$ 20.14
US$ 29.18
US$ 29.84
